| Dr Antoinette G Quigley, MD | |
|
1375 E 20th Ave, Denver, CO 80205-5423 | |
| (303) 338-4545 | |
| Not Available |
| Full Name | Dr Antoinette G Quigley |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Neurology |
| Location | 1375 E 20th Ave, Denver, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033253752 | NPI | - | NPPES |
| 01292820 | Medicaid | CO | |
| 005191 | Other | KAISER-COMMERCIAL NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 29282 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Antoinette G Quigley, MD 2500 S Havana St, Aurora, CO 80014-1618 Ph: (303) 338-3339 | Dr Antoinette G Quigley, MD 1375 E 20th Ave, Denver, CO 80205-5423 Ph: (303) 338-4545 |
News Archive
The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it has awarded a grant of $228,668 to Cognition Therapeutics (CogRx) to develop small molecule drugs that block the action of the toxic "oligomers" thought responsible for Alzheimer's disease (AD).
Obesity is known to cluster in families, but most studies to date are limited to two generations. A new Pediatric Obesity study is the first to prospectively examine the relationship between grandparent and grandchild abdominal obesity.
Scientists here have found that certain substances from bacteria living in the human intestine cause the normally harmless Candida albicans fungus to become highly infectious.
In 2010, the American Society of Anesthesiologists® (ASA®) introduced a mannequin-based simulation program to satisfy the American Board of Anesthesiology requirements for Maintenance of Certification in Anesthesiology (MOCA).
InterMune, Inc. announced today that the U.S. Food and Drug Administration (FDA) has posted briefing documents for the March 9 Pulmonary-Allergy Drugs Advisory Committee (PADAC) meeting to review the New Drug Application (NDA) for pirfenidone, InterMune's investigational drug candidate for the treatment of patients with idiopathic pulmonary fibrosis (IPF) to reduce decline in lung function. The proposed trade name for pirfenidone is Esbriet®.
› Verified 6 days ago
Stefan Michael Bumol, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4455 E 12th Ave, Denver, CO 80220 Phone: 303-504-7700 | |
Dr. Todd M. Kline, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 155 S Madison St, 216, Denver, CO 80209 Phone: 720-360-6375 | |
Gary Lee Martz, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1721 E 19th Ave, Suite 528, Denver, CO 80218 Phone: 303-813-1400 Fax: 303-813-1401 | |
Dr. Jeffrey Lee Metzner, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3300 E 1st Ave, Suite 590, Denver, CO 80206 Phone: 303-355-6842 Fax: 303-322-2155 | |
James Trevor Mcnutt, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4545 E 9th Ave, Suite 510, Denver, CO 80220 Phone: 303-321-0700 Fax: 303-321-0811 | |
Dr. Lori Greene, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 10350 E Dakota Ave, Denver, CO 80247 Phone: 303-338-3800 | |
Dr. Katherine Riva, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 777 Bannock St, Denver, CO 80204 Phone: 303-724-6019 |